Totient
Cambridge
About Totient
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2021)
- Website: totient.bio
- Phone: +1 (617) 221-8986
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/totient-87777 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.